Skip to main content
. 2011 Jan;60(1-6):32–42. doi: 10.1016/j.metabol.2009.12.015

Fig. 4.

Fig. 4

Heparin-releasable and tissue LPL activity from rat hearts after treatment with low- or high-dose metformin and AICAR. Total LPL estimated as sum of heparin-releasable and tissue residual LPL. Data represent mean ± SD (n = 6 hearts in all groups). Statistical significance represented as different from control: *P < .05 and **P < .01.